BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11306517)

  • 21. Aberrant activation of interleukin-9 receptor and downstream Stat3/5 in primary T-cell lymphomas in vivo in susceptible B6 and resistant C3H mice.
    Shang Y; Kakinuma S; Amasaki Y; Nishimura M; Kobayashi Y; Shimada Y
    In Vivo; 2008; 22(6):713-20. PubMed ID: 19180996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1.
    Xie W; Su K; Wang D; Paterson AJ; Kudlow JE
    Anticancer Res; 1997; 17(4A):2627-33. PubMed ID: 9252692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p91 STAT1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells.
    Aronica MG; Brizzi MF; Dentelli P; Rosso A; Yarden Y; Pegoraro L
    Oncogene; 1996 Sep; 13(5):1017-26. PubMed ID: 8806691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells.
    Nakamura N; Fujii M; Tsukahara T; Arai M; Ohashi T; Wakao H; Kannagi M; Yamamoto N
    Oncogene; 1999 Apr; 18(17):2667-75. PubMed ID: 10348340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF-induced activation of Stat1, Stat3, and Stat5b is unrelated to the stimulation of DNA synthesis in cultured hepatocytes.
    Guren TK; Abrahamsen H; Thoresen GH; Babaie E; Berg T; Christoffersen T
    Biochem Biophys Res Commun; 1999 May; 258(3):565-71. PubMed ID: 10329425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of STAT proteins and growth control.
    Bromberg JF
    Bioessays; 2001 Feb; 23(2):161-9. PubMed ID: 11169589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Members of the family of IL-6-type cytokines activate Stat5a in various cell types.
    Piekorz RP; Nemetz C; Hocke GM
    Biochem Biophys Res Commun; 1997 Jul; 236(2):438-43. PubMed ID: 9240457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells.
    Sun SC; Maggirwar SB; Harhaj EW; Uhlik M
    Oncogene; 1999 Feb; 18(7):1401-9. PubMed ID: 10050877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest.
    Narimatsu M; Nakajima K; Ichiba M; Hirano T
    Biochem Biophys Res Commun; 1997 Sep; 238(3):764-8. PubMed ID: 9325164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ly-6A/E induction by interleukin-6 and interleukin-9 in T cells.
    Demoulin JB; Maisin D; Renauld JC
    Eur Cytokine Netw; 1999 Mar; 10(1):49-56. PubMed ID: 10210773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.
    O'Farrell AM; Liu Y; Moore KW; Mui AL
    EMBO J; 1998 Feb; 17(4):1006-18. PubMed ID: 9463379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice.
    Wüstefeld T; Rakemann T; Kubicka S; Manns MP; Trautwein C
    Hepatology; 2000 Sep; 32(3):514-22. PubMed ID: 10960443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M; De Vos J; Mechti N; Klein B
    Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 activation accompanies keratinocyte differentiation.
    Hauser PJ; Agrawal D; Hackney J; Pledger WJ
    Cell Growth Differ; 1998 Oct; 9(10):847-55. PubMed ID: 9790496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor-induced growth inhibition requires Stat1 activation.
    Bromberg JF; Fan Z; Brown C; Mendelsohn J; Darnell JE
    Cell Growth Differ; 1998 Jul; 9(7):505-12. PubMed ID: 9690618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
    Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
    Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation.
    Huss R; Gatsios P; Graeve L; Lange C; Eissner G; Kolb HJ; Thalmeier K; Heinrich PC
    Cytokine; 2000 Aug; 12(8):1195-204. PubMed ID: 10930296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT signaling in the pathogenesis and treatment of leukemias.
    Lin TS; Mahajan S; Frank DA
    Oncogene; 2000 May; 19(21):2496-504. PubMed ID: 10851048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of IFNγR2 mutated in a dileucine internalization motif reinstates IFNγ signaling and apoptosis in human T lymphocytes.
    Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F
    Immunol Lett; 2010 Nov; 134(1):17-25. PubMed ID: 20709103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.